Lipoprotein(a) or Lp(a) is a genetically controlled risk factor for a heart attack. Cardiologist explains why it's important to be aware of your levels.

Thirty-year outcomes among participants in the Women's Health Study showed a stepwise increase in major cardiovascular events associated with increasing lipoprotein(a) levels starting around 30-60 ...

FDA expands Juxtapid approval for pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia to reduce plasma LDL-C levels.

Lipoprotein(a) has been studied as a risk factor for coronary heart disease, but whether a causal relationship exists has been unclear. A study by Kamstrup and colleagues examining genetically ...

Inclisiran, an siRNA therapy, significantly reduces LDL-C by 28.5% in adolescents with heterozygous familial hypercholesterolemia (HeFH).

Anjali advises that specific nutrients could aid in the progressive reduction of Lp(a) levels When people think about cholesterol and heart health, they usually focus on total cholesterol and LDL ...

Increased levels of lipoprotein(a), a variant of "bad cholesterol" in the bloodstream, are a risk factor for recurrent coronary heart disease (CHD) in people aged 60 or over, according to the results ...

In a recent study published in the journal Current Medical Research and Opinion, researchers report that high lipoprotein(a) levels were linked to repeated coronary heart disease events in older ...